Home » Topics » Conferences

Conferences
RSS

Targretin as novel therapy for refractory breast cancer: preclinical studies

April 21, 1999

Angiotensin immunization as an immunotherapeutic approach to hypertension

April 21, 1999

AACR news: squalamine evaluated for activity in prostate and lung cancer models

April 20, 1999

Potent and long-lasting GnRH antagonist presented by Ferring

April 20, 1999

Eisai research team discovers novel HIV-1 Tat antagonist

April 20, 1999

Preclinical study supports antinociceptive efficacy of ET-A antagonist

April 20, 1999

News from FASEB: YM-905 is a bladder-specific M3 receptor antagonist

April 20, 1999

Avant Immunotherapeutics' CETP vaccine is effective in rabbit models of atherosclerosis

April 20, 1999

SBR-170: a new bioreductive alkylating agent selected for further evaluation

April 20, 1999

News from FASEB: novel botanical product for treatment of Alzheimer's disease

April 20, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 15, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 15, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
LINC01116 has prognostic value in lung cancer, study shows
BioWorld MedTech
Long noncoding RNAs (lncRNAs) have emerged as potential markers of disease, since they associate with proteins that regulate gene expression, translation or...
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...